Priska Spiri-Nakagawa

Studies on bacterial cell wall inhibitors. VII. Azureomycins A and B, new antibiotics produced by Pseudonocardia azurea nov. sp. Taxonomy of the producing organism, isolation, characterization and biological properties.

Satoshi Ōmura, Haruo Tanaka, Yoshitake Tanaka et al. · The Journal of Antibiotics · 1979 · 38 citations · Full text

Life Sciences, Biotechnology, Microbiology +13

Izupeptins A and B, new glycopeptide antibiotics produced by an actinomycete.

Priska Spiri-Nakagawa, Y. Fukushi, Kazunori Maebashi et al. · The Journal of Antibiotics · 1986 · 17 citations · Full text

Life Sciences, Microbiology, Drug Discovery +11

The mode of action of cervinomycin in Staphylococcus aureus.

Haruo Tanaka, Kazuhito Kawakita, Hidekazu Suzuki et al. · The Journal of Antibiotics · 1989 · 17 citations · Full text

Life Sciences, Microbiology, Pharmacology +12

Studies on bacterial cell wall inhibitors. VIII. Mode of action of a new antibiotic, azureomycin B, in Bacillus cereus T.

Priska Spiri-Nakagawa, Yoshitake Tanaka, RUIKO OIWA et al. · The Journal of Antibiotics · 1979 · 13 citations · Full text

Medicine, Microbiology, Pharmacology +13